Trial Details

UNKNOWN
Basic Information
Clinical ID c1396
Identifier NCT05386290
Trial Title A Multicentered Prospective Cohort Study of Chinese IBD Patients
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis|Crohn Disease
Interventions DRUG: Infliximab|DRUG: Vedolizumab|DRUG: Ustekinumab|DRUG: conventional treatment (glucocoticoid, immunosupressive drugs and/or mesalazine)
Participant Information
Sponsor Peking Union Medical College Hospital
City Beijing
Country/Region China
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2020-07-09
Primary Completion Date 2025-09-23
Completion Date 2025-12-23